VIRGINIA HOSPITAL CENTER ARLINGTON
1. Target Overview & Investment Thesis
VIRGINIA HOSPITAL CENTER ARLINGTON is a 336-bed suburban community hospital in ARLINGTON, VA with $624.4M in net patient revenue and a 1.8% operating margin. The hospital serves a payer mix of 23.2% Medicare, 2.5% Medicaid, and 74.3% commercial.
Thesis: Undervalued. Our ML models identify $46.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 1.8% to 9.1% (+736bps).
| Net Revenue HCRIS | $624.4M |
| Current EBITDA COMPUTED | $10.9M |
| Operating Margin COMPUTED | 1.8% |
| Occupancy HCRIS | 86.1% |
| Revenue / Bed COMPUTED | $1.9M |
| Net-to-Gross HCRIS | 31.4% |
| Distress Probability ML | 39.3% |
2. Market Context & Competitive Position
VA has 111 Medicare-certified hospitals with a median operating margin of 4.4%. The target's margin of 1.8% places it below the state median. Among 26 size-comparable peers (168-672 beds), the median margin is 6.8%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (168-672), prioritizing same-state peers. 26 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| VIRGINIA HOSPITAL CENTER ARLIN (Target) | VA | 336 | $624.4M | 1.8% |
| UNIVERSITY OF VIRGINIA MEDICAL | VA | 665 | $2.37B | 1.1% |
| CARILION MEDICAL CENTER | VA | 637 | $1.46B | -11.3% |
| SENTARA NORFOLK GENERAL HOSPIT | VA | 472 | $1.34B | 4.9% |
| CJW MEDICAL CENTER | VA | 612 | $1.00B | 32.8% |
| RIVERSIDE REGIONAL MEDICAL CEN | VA | 379 | $963.3M | -20.1% |
| WINCHESTER MEDICAL CENTER | VA | 455 | $694.7M | -5.8% |
| ST. MARYS HOSPITAL | VA | 363 | $688.9M | 13.3% |
| MARY WASHINGTON HOSPITAL | VA | 440 | $552.1M | 1.7% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $46.0M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $13.1M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $12.5M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $12.4M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $7.6M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $400K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $10.9M |
| + RCM Uplift | +$46.0M |
| Pro Forma EBITDA | $56.9M |
| Current Margin | 1.8% |
| Pro Forma Margin | 9.1% |
| WC Released (1x) | $23.9M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $16.8M | $531.6M | 31.63x | 99.5% |
| Base (11x exit) | 10.0x | 11.0x | $16.8M | $590.3M | 35.12x | 103.8% |
| Bull Case | 9.0x | 11.0x | $15.1M | $747.4M | 49.40x | 118.2% |
| Bull (12x exit) | 9.0x | 12.0x | $15.1M | $819.8M | 54.19x | 122.2% |
| Bear Case | 11.0x | 10.0x | $18.5M | $296.4M | 16.03x | 74.2% |
| Bear (11x exit) | 11.0x | 11.0x | $18.5M | $332.0M | 17.96x | 78.2% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 26 hospitals with 168-672 beds
- Same-state prioritization (n=27)
- Comp margins: P25=0.7% / P50=6.8% / P75=15.1%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.